Santhera Pharmaceuticals Capital Markets Day to Discuss the Duchenne Muscular Dystrophy Treatment Landscape and Santhera’s Commercial Strategy
| DATE: | March 24, 2025 |
|---|---|
| TIME: | 9:00 AM EDT |
| LOCATION: | Virtual |
About The Event
Join Santhera for its virtual Capital Markets Day where Dario Eklund, CEO, Shabir Hasham, CMO, and Catherine Isted, CFO, will provide an update on Santhera’s strategy and direction as it transforms into a commercial life sciences company. In addition, key opinion leader (KOL) Professor Luca Bello, MD, PHD (University of Padova), will provide additional medical insights into Duchenne Muscular Dystrophy (DMD).
Agenda for Capital Markets Day:
- Introduction & Strategy
- CMO Presentation
- Fireside Chat
- Commercial Presentation
- CFO Presentation
- Wrap-up & Q&A